Skip to content

TXG

10x Genomics, Inc.

NASDAQ · USHealthcareMedical - Healthcare Information Services
$43.39-0.80%

Price as of Jul 20, 2026

TXG ownership

10x Genomics, Inc. ownership & insider activity

Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$2.6M
Insider trades by month Buys Sells
Nov
Feb
Mar
Apr
May
Jun
Context3-month price +77.9%Institutions mixed (13F)
DateInsiderTypeSharesPrice
Jun 24, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell8,527$33.29
Jun 24, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell9,821$35.32
Jun 24, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell1,661$36.16
Jun 24, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell9,991$34.28
Jun 18, 2026SULIMAN SHEHNAAZdirectorSell5,359$32.59
Jun 18, 2026SULIMAN SHEHNAAZdirectorSell364$33.27
Jun 8, 2026MATEO ALANdirectorGrant8,829
Jun 8, 2026Teichmann Sarah A.directorGrant8,829
Jun 8, 2026Popovits Kimberly JdirectorGrant8,829
Jun 8, 2026SULIMAN SHEHNAAZdirectorGrant8,829
Jun 8, 2026Kosaraju SridhardirectorGrant8,829
Jun 8, 2026STUELPNAGEL JOHN RdirectorGrant8,829
May 27, 2026Hindson Benjamin J.director, officer: See RemarksSell11,595$24.44
May 27, 2026Taich Adamofficer: Chief Financial OfficerSell15,098$24.44
May 27, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell10,718$24.71
May 27, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell18,175$24.44
Apr 16, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell5,000$24.56
Mar 25, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell10,000$19.13
Mar 25, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell5,000$19.52
Mar 4, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell14,292$22.67
Mar 4, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell1,860$23.18
Mar 2, 2026Hindson Benjamin J.director, officer: See RemarksGrant88,816
Mar 2, 2026Taich Adamofficer: Chief Financial OfficerGrant106,579
Mar 2, 2026Saxonov Sergedirector, officer: Chief Executive OfficerGrant157,895
Feb 27, 2026Teichmann Sarah A.directorSell7,579$19.41
Feb 25, 2026Hindson Benjamin J.director, officer: See RemarksSell7,826$18.58
Feb 25, 2026Taich Adamofficer: Chief Financial OfficerSell8,968$18.58
Feb 25, 2026Saxonov Sergedirector, officer: Chief Executive OfficerSell9,632$18.58
Jan 7, 2026Saxonov Sergedirector, officer: Chief Executive OfficerOption17,463$1.20
Jan 7, 2026Saxonov Sergedirector, officer: Chief Executive OfficerOption50,000$1.20

Source: TXG SEC Form 4 filings, latest Jun 24, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their TXG positions over the last 6 months (SEC Form 13F).

Increased
233
New positions
119
Reduced
208
Sold out
100
Largest moves
InstitutionActionSharesFiled
FMR LLCIncreased17.7MMay 15, 2026
VANGUARD GROUP INCReduced13.0MJan 29, 2026
ARK INVESTMENT MANAGEMENT LLCIncreased12.7MFeb 11, 2026
FMR LLCIncreased11.9MFeb 17, 2026
ARK INVESTMENT MANAGEMENT LLCReduced11.7MMay 12, 2026
BLACKROCK, INC.Increased10.1MMay 13, 2026
BLACKROCK, INC.Increased10.0MFeb 12, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position6.9MMay 8, 2026
SUMITOMO MITSUI TRUST HOLDINGS, INC.Increased5.5MJan 23, 2026
NIKKO ASSET MANAGEMENT AMERICAS, INC.Increased5.5MFeb 11, 2026
QUANTINNO CAPITAL MANAGEMENT LPIncreased5.4MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position5.3MMay 15, 2026
SUMITOMO MITSUI TRUST HOLDINGS, INC.Reduced5.1MApr 30, 2026
NIKKO ASSET MANAGEMENT AMERICAS, INC.Reduced5.1MMay 7, 2026
QUANTINNO CAPITAL MANAGEMENT LPIncreased4.7MFeb 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.